Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing. uri icon

Overview

publication date

  • November 8, 2022

Identity

PubMed Central ID

  • PMC9885954

Scopus Document Identifier

  • 85141241473

Digital Object Identifier (DOI)

  • 10.1016/j.immuni.2022.09.015

PubMed ID

  • 36351377

Additional Document Info

volume

  • 55

issue

  • 11